Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study

No Thumbnail Available

Authors

Narod, S. A.
Brunet, J. S.
Ghadirian, P.
Robson, M.
Heimdal, K.
Neuhausen, S. L.
Stoppa-Lyonnet, D.
Lerman, C.
Pasini, B.
de los Rios, P.
Show 3 more

Issue Date

2000

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Narod, SA; Brunet, JS; Ghadirian, P.; Robson, M.; Heimdal, K.; Neuhausen, SL; Stoppa-Lyonnet, D.; Lerman, C.; Pasini, B.; de los Rios, P.; Weber, B.; Lynch, H.; Hereditary Breast Canc Clin Study. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet. 2000, DEC 2. 356(9245):1876-1881.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/71762

PubMed ID

11130383

DOI

ISSN

0140-6736
0023-7507
1474-4465

EISSN

Collections

Faculty Bibliography Database